Provided by Tiger Trade Technology Pte. Ltd.

ALPHA COGNITION INC

9.75
+0.25002.63%
Volume:294.45K
Turnover:2.85M
Market Cap:211.99M
PE:-8.97
High:10.10
Open:9.62
Low:9.36
Close:9.50
52wk High:10.10
52wk Low:4.50
Shares:21.74M
Float Shares:15.06M
Volume Ratio:1.18
T/O Rate:1.96%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0868
EPS(LYR):-1.1790
ROE:-49.53%
ROA:-30.39%
PB:4.00
PE(LYR):-8.27

Loading ...

Alpha Cognition Announces Election of DR. Robert Wills as Chairman of the Board

THOMSON REUTERS
·
Jun 23

Alpha Cognition - Len Mertz Retires From Board

THOMSON REUTERS
·
Jun 23

Alpha Cognition Insiders Still US$88k Away From Original Investment Value

Simply Wall St.
·
Jun 18

Alpha Cognition's Phase 4 Trial of Zunveyl Completes Patient Enrollment

MT Newswires Live
·
Jun 16

Alpha Cognition announces enrollment of first patient in Resolve

TIPRANKS
·
Jun 16

Alpha Cognition Announces First Patient Enrolled in Resolve Phase 4 Study Evaluating Zunveyl® in Patients With Mild to Moderate Alzheimer’s Disease

THOMSON REUTERS
·
Jun 16

Opaleye Management reports Alpha Cognition common share purchase worth $45,845.95

Reuters
·
Jun 16

Opaleye Management acquires Alpha Cognition shares worth $184,037

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Alpha Cognition Inc (ACOG), Zenas BioPharma, Inc. (ZBIO)

TIPRANKS
·
Jun 11

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 11

Opaleye Management acquires Alpha Cognition common shares worth $58,589.64

Reuters
·
Jun 10

Analysts Are Bullish on These Healthcare Stocks: Zevra Therapeutics (ZVRA), Alpha Cognition Inc (ACOG)

TIPRANKS
·
Jun 10

BUZZ-U.S. STOCKS ON THE MOVE-Cleveland-Cliffs, Ciena Corp, Nokia Oyj

Reuters
·
Jun 09

BUZZ-U.S. STOCKS ON THE MOVE-Toll Brothers, TG Therapeutics, CECO Environmental

Reuters
·
Jun 09

BUZZ-Alpha Cognition surges as study shows Alzheimer’s drug improves cognition, behavior

Reuters
·
Jun 09

Alpha Cognition - Providers Report Delayed or Discontinued Psychotropic Medications in 80% of Zunveyl Patients

THOMSON REUTERS
·
Jun 09

Alpha Cognition - Providers Report Favorable Gi Tolerability and Overall Experience With Zunveyl

THOMSON REUTERS
·
Jun 09

Alpha Cognition Reports Positive Top-Line Results From Beacon Real-World Study of Zunveyl® in Alzheimer’s Disease

THOMSON REUTERS
·
Jun 09

Alpha Cognition - Providers Report Improved Sleep-Related Outcomes in 72% of Zunveyl Patients

THOMSON REUTERS
·
Jun 09

Opaleye Management reports $436,707 Alpha Cognition common-share purchase

Reuters
·
May 30